NovoCure Limited Ordinary Shares (NVCR) is a publicly traded Healthcare sector company. As of October 28, 2026, NVCR trades at $14.62 with a market cap of $1.68B and a P/E ratio of -10.87. NVCR moved +1.60% today. Year to date, NVCR is +11.43%; over the trailing twelve months it is +7.66%. Its 52-week range spans $9.82 to $21.55. Rallies surfaces NVCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NovoCure Limited Ordinary Shares (NVCR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NVCR moved +1.60% today.
| Metric | Value |
|---|---|
| Price | $14.62 |
| Market Cap | $1.68B |
| P/E Ratio | -10.87 |
| EPS | $-1.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.55 |
| 52-Week Low | $9.82 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $699.19M |
| Net Income | $-148.56M |
| Gross Margin | 76.13% |
NVCR analyst coverage data. Average price target: $0.00.